DNLI
Denali Therapeutics Inc.Company with tickers: DNLI
CIK
1714899
CUSIP
24823R105
Shares Outstanding
158,709,737
13F Activity (30d)
146 filings
145 filers
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding DNLI
10 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported |
|---|---|---|---|---|---|---|
| abrdn Healthcare Investors | HQH | 1,189,730 | $22,842,816 | 2.01% | Long | 2026-03-31 |
| abrdn Life Sciences Investors | HQL | 664,716 | $12,762,547 | 2.28% | Long | 2026-03-31 |
| TEKLA HEALTHCARE INVESTORS | HQH | 214,498 | $4,425,094 | 0.48% | Long | 2023-09-30 |
| TEKLA LIFE SCIENCES INVESTORS | HQL | 110,331 | $2,276,129 | 0.57% | Long | 2023-09-30 |
| BlackRock Health Sciences Term Trust | BMEZ | 78,053 | $1,498,618 | 0.15% | Long | 2026-03-31 |
| BlackRock Health Sciences Trust | BME | 22,218 | $426,586 | 0.08% | Long | 2026-03-31 |
| Guggenheim Active Allocation Fund | GUG | 1,062 | $22,493 | 0.00% | Long | 2026-02-27 |
| Gabelli Healthcare & WellnessRx Trust | GRX | 1,000 | $19,200 | 0.01% | Long | 2026-03-31 |
| Saba Capital Income & Opportunities Fund | BRW | 759 | $16,501 | 0.00% | Short | 2026-01-31 |
| Saba Capital Income & Opportunities Fund II | SABA | 876 | $19,044 | -0.01% | Short | 2026-01-31 |
Showing 1–10 of 10 positions